WEBULL
News
ORMP
3.410
+5.25%
0.170
Weekly Report: what happened at ORMP last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at ORMP last week (0119-0123)?
Weekly Report · 01/26 10:19
MRNA is S&P 500’s top performing stock, here are the best Quant pharma companies
Seeking Alpha · 01/21 19:36
Weekly Report: what happened at ORMP last week (0112-0116)?
Weekly Report · 01/19 10:25
Oramed Pharm pivots with Lifeward strategic platform deal
TipRanks · 01/14 22:00
Oramed Transfers Oral Drug Platform to Lifeward in Strategic Deal
Reuters · 01/14 21:32
Oramed To Transfer POD Technology To Lifeward; To Receive 49.9% Beneficial Ownership Interest
NASDAQ · 01/13 13:52
Lifeward To Issue $10M In Senior Secured Convertible Notes In A Private Placement, Of Which Oramed To Invest $9M, And An Additional Milestone-Based $10M Senior Secured Convertible Note, Of Which Oramed Will Invest $9M, Each With 100% Warrant Coverage
Benzinga · 01/13 13:21
Lifeward To Acquire Oramed's POD Technology And Secure Up To $47M Strategic Investment As Oramed Takes Up To 49.99% Stake
Benzinga · 01/13 13:18
Oramed and Lifeward sign strategic transaction
TipRanks · 01/13 13:05
Oramed Pharmaceuticals To Acquire 49.99% Stake In 49.99%, To Integrate Proprietary Protein Oral Delivery Technology; Lifeward To Issue $10M Convertible Notes, Oramed To Invest $9M Of Convertible Notes
Benzinga · 01/13 13:04
Lifeward Secures Up to $47 Million Equity Investment From Oramed for Minority Stake
Reuters · 01/13 13:03
LIFEWARD LTD - ORAMED TO BUY UP TO 49.99% EQUITY IN LIFEWARD
Reuters · 01/13 13:00
LIFEWARD LTD - BUYS ORAMED'S POD TECHNOLOGY FOR BIOTECH MARKET
Reuters · 01/13 13:00
LIFEWARD ENTERS TRANSFORMATIVE STRATEGIC INVESTMENT AND PARTNERSHIP AGREEMENT WITH ORAMED TO CREATE A DIVERSIFIED BIOMEDICAL INNOVATION COMPANY
Reuters · 01/13 13:00
BRIEF-Oramed And Lifeward Announce Strategic Transaction
Reuters · 01/13 12:59
Oramed Invests $9 Million in Lifeward and Transfers Oral Drug Delivery Technology
Reuters · 01/13 12:58
ORAMED PHARMACEUTICALS INC - LIFEWARD TO ISSUE $10 MLN CONVERTIBLE NOTES
Reuters · 01/13 12:58
Oramed and Lifeward Announce Strategic Transaction
PR Newswire · 01/13 12:58
Weekly Report: what happened at ORMP last week (0105-0109)?
Weekly Report · 01/12 10:24
More
Webull provides a variety of real-time ORMP stock news. You can receive the latest news about Oramed Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About ORMP
Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.